Status:
RECRUITING
Validation of the C-mo System - Cough Monitoring
Lead Sponsor:
Cough Monitoring Medical Solutions
Collaborating Sponsors:
Universidade Nova de Lisboa
Conditions:
Cough
Asthma
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
The goal of this clinical study is to validate C-mo System's ability to automatically detect and characterise cough, in patients over 2 years old with cough as a key or refractory symptom. The main q...
Eligibility Criteria
Inclusion
- Patients aged 2 years or older;
- Patients with symptoms/complaints of cough;
- Signed Informed Consent (age ≥ 18 years), signed Informed Consent from the parents/legal representative and the patient (16 and 17 years), or signed Informed Assent and Consent (5 years ≤ age ≤ 15 years).
Exclusion
- Presence of musculoskeletal (e.g., severe scoliosis), neurological (e.g., post stroke), cardiac (e.g., unstable angina), cognitive (e.g., dementia) changes, or other significant conditions that hinder the participants from collaborating in the collection of data.
- Damaged/weakened skin at the C-mo wearable device's placement area (epigastric region).
- Absence of Informed Consent and/or Assent, as applicable.
Key Trial Info
Start Date :
December 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
245 Patients enrolled
Trial Details
Trial ID
NCT05989698
Start Date
December 11 2023
End Date
September 1 2026
Last Update
September 10 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
HPAV - Trofa Saúde Hospital de Alfena
Alfena, Portugal
2
HFF - Hospital Professor Doutor Fernando Fonseca
Amadora, Portugal
3
Lab3R - Laboratório de Investigação e Reabilitação Respiratória da Escola Superior de Saúde da Universidade de Aveiro
Aveiro, Portugal
4
CHUC - Centro Hospitalar e Universitário de Coimbra
Coimbra, Portugal